Strong Growth in HIFU Revenue
Global HIFU revenues reached USD 9.7 million, marking an 89% year-over-year increase, driven by the net placement of 12 Focal One systems, which is a 140% growth compared to Q2 2024.
Focal One System Expansions
Significant growth in the adoption of Focal One systems, including placements at Cleveland Clinic facilities worldwide and an additional system at major hospital networks like Hackensack Meridian Health and Baptist Health.
Positive Reimbursement Developments
The Centers for Medicare and Medicaid Services proposed a 5.6% increase in hospital payment for Focal One HIFU procedures in 2026, with higher physician fees compared to other prostate ablation methods.
Progress in Endometriosis Treatment
Received CE marking for the use of HIFU in treating rectal endometriosis, with commercialization efforts initiated in Europe.
Strategic Financing Facility
Entered into a letter of intent for a strategic financing facility with the European Investment Bank for EUR 36 million (USD 42 million) to support the expansion of Focal One and new clinical indications.